Development of Melanoma and Other Nonkeratinocyte Skin Cancers After Thyroid Cancer Radiation.
作者信息
Rezaei Shawheen J, Chen Michael L, Kim Jiyeong, John Esther M, Sunwoo John B, Linos Eleni
机构信息
Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Center for Digital Health, Stanford University, Stanford, California.
出版信息
JAMA Netw Open. 2024 Sep 3;7(9):e2434841. doi: 10.1001/jamanetworkopen.2024.34841.
Abstract
摘要
相似文献
1
Development of Melanoma and Other Nonkeratinocyte Skin Cancers After Thyroid Cancer Radiation.甲状腺癌放疗后黑色素瘤及其他非角质形成细胞皮肤癌的发生
JAMA Netw Open. 2024 Sep 3;7(9):e2434841. doi: 10.1001/jamanetworkopen.2024.34841.
2
Incidence of Nonkeratinocyte Skin Cancer After Breast Cancer Radiation Therapy.乳腺癌放疗后非角质形成细胞皮肤癌的发病率。
JAMA Netw Open. 2024 Mar 4;7(3):e241632. doi: 10.1001/jamanetworkopen.2024.1632.
3
Malignant melanoma arising in a radiotherapy field: report of two cases and review of the literature.放疗野内发生的恶性黑色素瘤：两例报告并文献复习
Dermatology. 2003;206(3):265-8. doi: 10.1159/000068891.
4
Relationship of fluorescent lights to malignant melanoma: another view.荧光灯与恶性黑色素瘤的关系：另一种观点
J Dermatol Surg Oncol. 1983 Oct;9(10):836-8. doi: 10.1111/j.1524-4725.1983.tb00741.x.
5
Malignant melanoma caused by UV-A suntan bed?由紫外线A晒黑床导致的恶性黑色素瘤？
Acta Derm Venereol. 1982;62(4):356-7.
6
Malignant melanoma developing in an irradiation field.在放射野内发生的恶性黑色素瘤。
Br J Radiol. 1988 Jun;61(726):519-20. doi: 10.1259/0007-1285-61-726-519.
7
Malignant melanoma following scalp irradiation?头皮放疗后发生恶性黑色素瘤？
Clin Exp Dermatol. 1999 Sep;24(5):425. doi: 10.1046/j.1365-2230.1999.00518.x.
8
[Ionizing radiation--(a) cause of malignant melanoma?].[电离辐射——恶性黑色素瘤的病因？]
Dermatol Monatsschr. 1989;175(2):69-75.
9
Tanning salons linked to increased skin cancer risk.晒黑沙龙与皮肤癌风险增加有关。
Mayo Clin Womens Healthsource. 2004 Apr;8(4):3.
10
Risk factors for cutaneous malignant melanoma: the Western Canada Melanoma Study.皮肤恶性黑色素瘤的危险因素：加拿大西部黑色素瘤研究
Recent Results Cancer Res. 1986;102:38-55. doi: 10.1007/978-3-642-82641-2_4.
引用本文的文献
1
Age-Specific Risk of Second Primary Malignant Neoplasm After Radioactive Iodine Treatment for Differentiated Thyroid Cancer.分化型甲状腺癌放射性碘治疗后第二原发性恶性肿瘤的年龄特异性风险
JAMA Otolaryngol Head Neck Surg. 2025 Aug 21. doi: 10.1001/jamaoto.2025.2626.
2
Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers.社论：内分泌相关癌症的靶向治疗与生物标志物研究进展
Front Endocrinol (Lausanne). 2024 Dec 11;15:1533623. doi: 10.3389/fendo.2024.1533623. eCollection 2024.
本文引用的文献
1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.放射性碘治疗儿童和青年分化型甲状腺癌与第二原发恶性肿瘤风险的关系。
J Clin Oncol. 2022 May 1;40(13):1439-1449. doi: 10.1200/JCO.21.01841. Epub 2022 Jan 19.
3
Radioactive iodine in differentiated thyroid cancer: a national database perspective.分化型甲状腺癌中的放射性碘：国家数据库视角。
Endocr Relat Cancer. 2019 Oct;26(10):795-802. doi: 10.1530/ERC-19-0292.
4
Increased melanoma risk in individuals with papillary thyroid carcinoma.患有甲状腺乳头癌的个体患黑色素瘤的风险增加。
JAMA Otolaryngol Head Neck Surg. 2014 May;140(5):423-7. doi: 10.1001/jamaoto.2014.78.
5
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.甲状腺癌放射性碘治疗后的第二原发性恶性肿瘤风险：一项系统评价和荟萃分析。
Thyroid. 2009 May;19(5):451-7. doi: 10.1089/thy.2008.0392.
Zotero 插件